Picture loading failed.

Pre-Made Samalizumab biosimilar, Whole mAb, Anti-CD200 Antibody: Anti-MRC/MOX1/MOX2/OX-2 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Samalizumab is a humanized monoclonal antibody designed for oncology indications.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-504-1mg 1mg 3090
GMP-Bios-ab-504-10mg 10mg Inquiry
GMP-Bios-ab-504-100mg 100mg Inquiry
GMP-Bios-ab-504-xmg >100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Pre-Made Samalizumab biosimilar, Whole mAb, Anti-CD200 Antibody: Anti-MRC/MOX1/MOX2/OX-2 therapeutic antibody
INN Name Samalizumab
TargetCD200
FormatWhole mAb
DerivationHumanized
Species ReactivityHuman
CH1 IsotypeIgG2
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-I
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2010
Year Recommended2011
CompaniesAlexion Pharmaceuticals;The Leukemia & Lymphoma Society
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedAcute myeloid leukaemia;Chronic lymphocytic leukaemia;Multiple myeloma;Solid tumours
Development Techna